Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription Articles published in J Clin Invest Retrieve available abstracts of 19 articles: HTML format

Single Articles

September 2022
1. BLANCO-DOMINGUEZ R, de la Fuente H, Rodriguez C, Martin-Aguado L, et al
   CD69 expression on regulatory T cells protects from immune damage after myocardial infarction.
   J Clin Invest. 2022 Sep 6. pii: 152418. doi: 10.1172/JCI152418.
   PubMed     Abstract available
   
   
   June 2022
2. LAGGERBAUER B, Engelhardt S
   MicroRNAs as therapeutic targets in cardiovascular disease.
   J Clin Invest. 2022;132.
   PubMed     Abstract available
   
   
   May 2022
3. GLINTON KE, Ma W, Lantz C, Grigoryeva LS, et al
   Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation.
   J Clin Invest. 2022;132.
   PubMed     Abstract available
   
   
   March 2022
4. HENRION D
   Modulating the immune response to reduce hypertension-associated cardiovascular damage.
   J Clin Invest. 2022;132.
   PubMed     Abstract available
   
   
   February 2022
5. FAILER T, Amponsah-Offeh M, Neuwirth A, Kourtzelis I, et al
   Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation.
   J Clin Invest. 2022 Feb 8. pii: 126155. doi: 10.1172/JCI126155.
   PubMed     Abstract available
   
   
   
6. HUMERES C, Shinde AV, Hanna A, Alex L, et al
   Smad7 effects on TGF-beta and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure.
   J Clin Invest. 2022;132.
   PubMed     Abstract available
   
   
   January 2022
7. BAILEY LR, Davis J
   If these myocytes could talk, they would speak the language of metabolites.
   J Clin Invest. 2022;132.
   PubMed     Abstract available
   
   
   
8. MUSUNURU K
   Moving toward genome-editing therapies for cardiovascular diseases.
   J Clin Invest. 2022;132.
   PubMed     Abstract available
   
   
   November 2021
9. JIANG K, Tu Z, Chen K, Xu Y, et al
   Gasdermin D inhibition confers antineutrophil mediated cardioprotection in acute myocardial infarction.
   J Clin Invest. 2021 Nov 9. pii: 151268. doi: 10.1172/JCI151268.
   PubMed     Abstract available
   
   
   October 2021
10. BRAKENHIELM E, Chen Y, Cao Y
    Lymphatics in the broken heart.
    J Clin Invest. 2021;131.
    PubMed     Abstract available
    
    
    September 2021
11. KNUTSON AK, Williams AL, Boisvert WA, Shohet RV, et al
    HIF in the heart: development, metabolism, ischemia, and atherosclerosis.
    J Clin Invest. 2021;131.
    PubMed     Abstract available
    
    
    August 2021
12. KELLER IV TCS, Lim L, Shewale SV, McDaid K, et al
    Genetic blockade of lymphangiogenesis does not impair cardiac function after myocardial infarction.
    J Clin Invest. 2021 Aug 17. pii: e147070. doi: 10.1172/JCI147070.
    PubMed     Abstract available
    
    
    July 2021
13. LIU M, Liu H, Parthiban P, Kang GJ, et al
    Inhibition of the unfolded protein response reduces arrhythmic risk after myocardial infarction.
    J Clin Invest. 2021 Jul 29. pii: e147836. doi: 10.1172/JCI147836.
    PubMed     Abstract available
    
    
    
14. PRABHU SD
    Healing and repair after myocardial infarction: the forgotten but resurgent basophil.
    J Clin Invest. 2021;131.
    PubMed     Abstract available
    
    
    
15. SICKLINGER F, Meyer IS, Li X, Radtke D, et al
    Basophils balance healing after myocardial infarction via IL-4/IL-13.
    J Clin Invest. 2021;131.
    PubMed     Abstract available
    
    
    April 2021
16. KASIKARA C, Schilperoort M, Gerlach B, Xue C, et al
    Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis.
    J Clin Invest. 2021;131.
    PubMed     Abstract available
    
    
    February 2021
17. DEBERGE M, Glinton K, Subramanian M, Wilsbacher LD, et al
    Macrophage AXL receptor tyrosine kinase inflames the heart after reperfused myocardial infarction.
    J Clin Invest. 2021 Feb 2. pii: 139576. doi: 10.1172/JCI139576.
    PubMed     Abstract available
    
    
    January 2021
18. CALIFF RM, Curtis LH, Harrington RA, Hernandez AF, et al
    Generating evidence for therapeutic effects: the need for well-conducted randomized trials.
    J Clin Invest. 2021;131.
    PubMed    
    
    
    March 2020
19. SIRAJ MA, Mundil D, Beca S, Momen A, et al
    Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-alpha.
    J Clin Invest. 2020;130:1392-1404.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: